Multi-Frequency Processing for Lumen Enhancement with Wideband Intravascular Ultrasound by Carrillo, Rory A
Multi-Frequency Processing for Lumen Enhancement with Wideband 
Intravascular Ultrasound 
 
 
 
 
A Thesis Presented to the Faculty of the  
Biomedical Engineering Department  
California Polytechnic State University, San Luis Obispo 
 
 
 
In Partial Fulfillment of the Requirements for the Degree of  
Master of Science in Engineering 
 
 
 
By 
Rory A. Carrillo 
September 2010
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2008 
Rory Allen Carrillo 
ALL RIGHTS RESERVED 
 iii 
COMMITTEE MEMBERSHIP 
 
TITLE: Multi-Frequency Processing for Lumen Enhancement with 
Wideband Intravascular Ultrasound 
 
AUTHOR:    Rory Allen Carrillo 
 
DATE SUBMITTED:  September 2010 
 
 
 
COMMITTEE CHAIR:  Dr. Lily Laiho 
 
COMMITTEE MEMBER:  Dr. Robert Crockett 
 
COMMITTEE MEMBER:  Dr. Lanny Griffin 
 
 iv 
Abstract 
Multi-Frequency Processing for Lumen Enhancement with Wideband Intravascular 
Ultrasound 
Rory Allen Carrillo 
 
The application of high frequency ultrasound is the key to higher resolution intravascular 
ultrasound (IVUS) images. The need to further improve the IVUS spatial resolution may 
drive the transducer center frequency even higher than the current 40 MHz range. 
However, increasing the center frequency may be challenging as it leads to stronger 
scattering echoes from blood. The high level of blood scattering echoes may obscure the 
arterial lumen and make image interpretation difficult. Blood backscatter levels increase 
with transmission center frequency at a much greater rate compared to arterial tissue. 
These different frequency dependencies provide a potential method to distinguish blood 
from tissues by means of multi-frequency processing techniques. To obtain a good blood-
tissue contrast with sufficient signal-to-noise ratio, a system with a wider bandwidth is 
highly desirable. The method described in this paper is based on the ratio of the received 
signal power between the high (60 MHz) and low (25 MHz) frequency ranges from a 
novel 40 MHz wideband IVUS catheter. In this paper we will present our in vitro 
experiment work on porcine blood and a tissue-mimicking arterial wall. Results of multi-
frequency processing indicate that blood, at higher frequencies, has a greater backscatter 
power that is 8X greater than arterial tissue, suggesting this technique will provide a 
greater contrast between the blood-wall lumen boundary for coronary imaging.  
. 
 v 
Acknowledgements 
I would like to thank everyone who supported me through all of my years of college. Thanks to 
my family: mother, Crissy; father, Ray; sister, Destiney; my best friends Mike, Joe, Dylan, and 
Bennett; and my Grandmother Elaine for being there every step of the way for me, so that I only 
had to worry about school, and for always encouraging me to reach higher, even though I didn’t 
think it would be possible. 
Thanks to my professors, who have inspired me to continue to learn and grow: 
• Dr. Lily Laiho for believing in me, being patient with me, and giving her best guidance 
throughout this thesis process. I can not thank her enough 
• Dr. Wenguang Li, who is one of the most well respected experts in the IVUS industry 
and is my colleague at Boston Scientific, to whom I cannot express enough appreciation and 
gratitude.  He has supported me and taught me to grow as not only a student, but an engineer.  
• Dr. Dan Walsh who believed in me when I applied to the Master’s program and 
transitioned from my bachelor’s degree of electrical engineering. 
• Dr. Lanny Griffin who has helped me tremendously during my last quarter in school and 
guided me throughout writing this thesis.  
 
Thanks to Cal Poly, San Luis Obispo, for providing the “learn by doing” environment where 
students are encouraged to continuously push the envelope and learn concepts outside of the 
classroom.  
I appreciate all of the support and help throughout this research process, and I hope this thesis 
will be helpful to others in the future. 
 
Rory A. Carrillo 
September 2010    
 vi 
Table of Contents 
List of Tables............................................................................................................................................... vii 
List of Figures ............................................................................................................................................ viii 
Chapter 1: Introduction............................................................................................................................... 1 
1.1 Background.......................................................................................................................................... 2 
1.1.1 The Circulatory System ............................................................................................................... 2 
1.1.2 Coronary Arteries......................................................................................................................... 3 
1.1.3 Atherosclerosis............................................................................................................................. 4 
1.1.4 Coronary Artery Diseases (CAD) ................................................................................................ 5 
1.1.5 Coronary Imaging Techniques..................................................................................................... 6 
1.1.6 History of Intravascular Ultrasound........................................................................................... 18 
Chapter 2: Basic Principles of Ultrasound............................................................................................... 21 
2.1 General............................................................................................................................................... 21 
2.2 Ultrasound Waves.............................................................................................................................. 22 
2.2.1 Frequency................................................................................................................................... 23 
2.2.2 Characteristics of Ultrasound..................................................................................................... 23 
2.2.3 Reflection and Refraction .......................................................................................................... 25 
2.2.4 Scattering ................................................................................................................................... 26 
2.2.5 Absorption and Attenuation ....................................................................................................... 27 
2.3 Ultrasound Transducer Properties...................................................................................................... 27 
2.3.1 Solid-State vs. Mechanical Transducer Elements ...................................................................... 28 
2.3.2 Resolution .................................................................................................................................. 29 
2.4 Intravascular Ultrasound System ....................................................................................................... 33 
2.5 Physical Properties of Tissue Relevant to IVUS ............................................................................... 35 
2.5.1 Properties of Arterial Tissue ...................................................................................................... 35 
2.5.2 Properties of Blood .................................................................................................................... 37 
2.5.3 Blood versus Arterial Tissue...................................................................................................... 39 
Chapter 3: Multi-Frequency Processing for Lumen Enhancement ....................................................... 41 
3.1 Overview ........................................................................................................................................... 41 
3.2 Materials and Methodology ............................................................................................................... 41 
3.2.1 Flow Phantom Setup .................................................................................................................. 42 
3.2.2 Vascular Phantom ...................................................................................................................... 46 
3.2.3 Intravascular Ultrasound Imaging System ................................................................................. 48 
3.2.4 Coronary Catheter ...................................................................................................................... 48 
3.2.5 Data Acquisition and Analysis................................................................................................... 50 
3.3 Results and Discussion ...................................................................................................................... 55 
3.3.1 In-Vitro Study ............................................................................................................................ 55 
3.3.1 In-Vivo Study............................................................................................................................. 59 
3.4 Conclusion ......................................................................................................................................... 60 
Bibliography................................................................................................................................................ 65 
 
 vii 
List of Tables 
Table 1: Physical and acoustic properties of blood-mimicking fluid. .......................................................... 45 
Table 2: Reynold's number and stability at varying mean flow velocities. .................................................. 47 
Table 3: MFSR results for whole porcine blood (37.5°C)............................................................................ 56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii 
List of Figures 
Figure 1: Drawings of coronary arteries and a cross-section of the heart....................................................... 3 
Figure 2: Progress of Coronary Artery Disease.............................................................................................. 6 
Figure 3: Coronary Angiography Image......................................................................................................... 8 
Figure 4: Illustration of Coronary Angiography Limitation ......................................................................... 11 
Figure 5: Coronary Remodeling ................................................................................................................... 12 
Figure 6: IVUS Catheter in Artery ............................................................................................................... 14 
Figure 7: IVUS image .................................................................................................................................. 14 
Figure 8: Multi-element and single element technologies ............................................................................ 29 
Figure 9: Axial Resolution Representation................................................................................................... 31 
Figure 10: Lateral Resolution Diagram ........................................................................................................ 33 
Figure 11: Basic IVUS System Block Diagram ........................................................................................... 33 
Figure 12: Blood Flow Model Diagram ....................................................................................................... 43 
Figure 13: Blood flow model setup .............................................................................................................. 45 
Figure 14: Velocity Profile Diagram ............................................................................................................ 47 
Figure 15: Frequency Response of High Bandwidth Transducer ................................................................. 49 
Figure 16 Blood and Tissue Frequency Response........................................................................................ 50 
Figure 17: Region of Interest (ROI) ............................................................................................................. 51 
Figure 18: Multi-frequency post-processing analysis flowchart................................................................... 54 
Figure 19: Mean Multi-Frequency Signal Ratio values................................................................................ 57 
Figure 20: Mean signal amplitudes. ............................................................................................................. 58 
Figure 21: In vivo coronary image showing visual enhancement of a thrombus. ........................................ 59 
Figure 22: Enhanced Image Analysis. .......................................................................................................... 63 
Chapter 1: Introduction 
 1 
Chapter 1: Introduction 
 According to the American Heart Association (AHA), in 2004 an estimated 79 
million American adults (1 in 3) suffered from Cardiovascular Diseases (CVD) and 
approximately 871,000 lives were taken.  Subsequently, Coronary Heart Disease (CHD) 
caused 1 of every 5 deaths in the U.S. in 2004.  About every 26 seconds, an American 
will suffer from a coronary attack, and about every minute someone will die from one.  
CHD is the single largest killer of Americans [1] .    
 In order to assess the nature of cardiovascular diseases in patients and provide 
sound feedback on the appropriate therapeutic interventions, it is necessary to develop 
techniques that are capable of evaluating cardiovascular morphology.  Until the end of 
the 20st century, coronary angiography was the principal method for assessment of the 
presence and severity for both peripheral and coronary artery disease. However, 
angiography has several limitations in underestimating the disease severity in vessels due 
to its silhouette like view of the coronary artery [2;3].  
Over the last 20 years, one major minimally invasive diagnostic technique has 
proven to be capable of defining cardiac morphology and functionality with great 
accuracy.  The technique known as Intravascular Ultrasound (IVUS) provides physicians 
with something other diagnostic techniques do not, higher-resolution tomographic 
images.  However, IVUS does not stand on its own. IVUS can provide physicians with a 
greater insight into a patient’s physiological nature when used in parallel with 
Angiography. 
 Intravascular Ultrasound and coronary angiography (also known as X-ray 
Fluoroscopy) attempt to alleviate the above statistics by combining an imaging modality 
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that provides high-resolution, accurate cross-sectional measurements of lesion 
morphology, and a contrast technique to reveal potential lesions within the coronary 
arteries.  Both techniques are combined and necessary in order to properly assess the 
severity and progression of coronary artery disease in patients, better helping physicians 
with proper diagnostic evaluations and interventional assessments.  
 
1.1 Background 
 The following sections will encompass all that is related to Intravascular 
Ultrasound, including: the circulatory system, coronary arteries, atherosclerosis, coronary 
artery disease, imaging modalities and their limitations, and finally, the history of 
Intravascular Ultrasound.   
 
1.1.1 The Circulatory System 
The human circulatory system consists of the heart, blood, veins, arteries and 
capillaries. The main function of the cardiovascular system is to deliver oxygen and 
nutrients to all tissues in the body and collect metabolic waste. Blood is a carrier for 
hormones and plays an important role in the immune system. The heart is the muscular 
organ which pumps blood. The right ventricle pumps deoxygenated blood into the 
pulmonary arteries, which carry the blood to the lungs, where it passes through a 
capillary network that enables the release of carbon dioxide and the uptake of oxygen. 
Oxygenated blood from the lungs returns to the heart via the pulmonary veins, and then 
flows from the left atrium into the left ventricle, which pumps blood through the aorta, 
the major artery that supplies blood to the body [4;5]. 
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1.1.2 Coronary Arteries 
The arteries that supply the heart muscle, or myocardium, with blood are the 
coronary arteries. These arteries are capable of maintaining blood flow at levels 
appropriate to the needs of the myocardium. There are two main coronary arteries; the 
left coronary artery (LCA) and the right coronary artery (RCA) – see Figure 1 below. 
The LCA arises from the aorta and bifurcates into the left anterior descending (LAD) 
artery and the left circumflex artery (LCX). Coronary arteries have an open space, also 
known as the lumen, through which blood flows with diameters ranging from 2 to 4 mm 
[4].  
 
 
Figure 1: Drawings of coronary arteries and a cross-section of the heart. [Image provided Boston 
Scientific] 
 
 
Normal arterial wall consists of three layers: intima, media, and adventitia. The 
intima is the innermost layer that consists of a permeable endothelial cell layer separating 
the blood from the vessel wall (roughly 50-150 µm). The internal elastic lamina separates 
the intima from the media and reduces turbulence of the flow of blood allowing it to be 
pumped farther. The media, which consist of smooth muscle cells, is the middle layer and 
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is approximately 200-300 µm and are used to contract or relax the to constrict or dilate 
the artery to enable blood flow management. The outermost layer, the adventitia, contains 
smooth muscle cells mixed with fibrous connective tissue and is known to act as a barrier 
from surrounding tissue. 
 
1.1.3 Atherosclerosis  
Atherosclerosis is a disease within the blood vessels. The early atherosclerotic 
lesion is associated with endothelial cell dysfunction. Cholesterol is delivered by low-
density lipoproteins (LDL) through the endothelial cells into the intima, where fatty 
deposits build up on the inside of the arterial wall [6]. This process causes monocytes, a 
type of white blood cell, to enter the intima and eventually turn into inflammatory cells 
called macrophages. Macrophages ingest oxidized cholesterol, delivered by the LDL, and 
slowly turn into large “foam cells.” Foam cells eventually die and further propagate the 
inflammatory process. Over a period of time, these foam cells develop into 
atherosclerotic lesions and increase in thickness. These atherosclerotic lesions, also 
known as plaques, initially expand into the arterial wall [7]. Intracellular micro-
calcification deposits form within vascular smooth muscle cells of the surrounding 
muscular layer, specifically in the muscle cells adjacent to the lesions. In time, as cells 
die, this leads to extracellular calcium deposits between the muscular wall and outer 
portion of the athersclerotic plaques. Plaques within the vessel wall are soft. The 
progressive plaques consist of fibrotic material or lipids (atheroma), cell debris, calcium 
crystals and fibrotic material covered by a thin cap (micron range) that has been formed 
by new connective tissue (fibroatheromas). During the progressive disease process, these 
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fibroatheromas initially do not restrict the lumen, because of outward remodeling of the 
vessel. However, in late stages, typically after decades, these fibroatheromas could 
expand into the lumen, narrowing the opening of the vessel and therefore reduce blood 
flow. Narrowing of a vessel is called a stenosis. The vasa vasorum are small microvessels 
within the adventitia of larger arteries (e.g. coronary arteries) that supply the walls of 
these arteries with nutrients. Vasa vasorum are assumed to play an important role in the 
generation of atherosclerotic plaque. [8;8] 
 
1.1.4 Coronary Artery Diseases (CAD) 
Coronary Artery Disease, a type of CHD, is the result of the accumulation of 
atheromatous plaques, or atherosclerosis, specifically within the walls of the coronary 
arteries that supply the muscle of the heart with oxygen and nutrients. The accumulation 
of plaque on the inner walls of the arteries causes the arteries to harden and narrow; 
arteries are normally smooth and elastic. As the plaque continues to build up, less blood 
can flow through the arteries, depriving the heart muscles of the oxygen necessary to 
function properly, which is called ischemia. Oxygen deprivation to the myocardial 
muscle fibers can lead to angina (chest pain) or in an extreme case, myocardial infarction 
(heart attack). Figure 2 provides an overview of the progress of CAD as described in the 
previous section (see 1.1.3 Atherosclerosis). According to the American Heart 
Association in 2007, it was reported that Coronary Artery Disease was the most common 
type of heart disease and was the leading cause of death in the United States among men 
and women [1;9].  
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Figure 2: Progress of Coronary Artery Disease 
 
Much effort has been performed in order to minimize CAD. As a result of numerous 
efforts, many diagnostic methods have been developed to aid physicians in the proper 
diagnosis of the disease that has and will continue to claim the lives of millions every 
year [1]. Intravascular Ultrasound and many other imaging modalities have been design 
to help physicians; however, each has their advantages and disadvantages. Currently, 
Intravascular Ultrasound has been the leading adjunct technology aiding physicians with 
determining the severity of diseases such as CAD [10].  
 
1.1.5 Coronary Imaging Techniques 
Cardiac catheterization was first described by Forsmann in 1929 [11], and in 1959 
it was developed by Sones [12;13], then modified by Judkins in 1967 [14]. Since then, 
cardiac catheterization has become the technique of choice to assess a patient with 
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coronary disease. Cardiac catheterization is simply a procedure that examines the blood 
flow to the heart and tests how well the heart is pumping. During the procedure, a 
physician inserts a catheter, or a thin plastic tube, into an artery of the arm or leg. From 
there the catheter is advanced into the chambers of the heart or into the coronary arteries 
where it can be used to monitor blood pressure, inject a dye for coronary angiography 
procedures, or even inflate a balloon to open up the arteries (this is known as Coronary 
Angioplasty). When assessing a patient for CAD, cardiac catheterization remains to be 
the only clinically accepted method to determine the presence and severity of CAD 
despite its costs as an estimated 2 million procedures were performed in 2000 [15]. Great 
strides have been made to enhance the ability to visualize the lumen of the coronary 
artery but all modalities have their limitations. The following section describes a few of 
the cardiac imaging modalities used for coronary artery assessment.   
Despite the many noninvasive techniques that can be used to help a physician 
diagnose a patient, the ability to insert a catheter within the vessel still has greater 
advantages as a diagnostic tool for clinical decision-making as it provides an inside look 
to what is physiologically occurring within the vessel. The number of catheterizations 
performed has continued to increase each year, proving to be the diagnostic tool of choice 
for cardiologists [15].  
Coronary Angiography 
Coronary angiography is defined as the graphic visualization of the coronary 
vessels after the injection of contrast media where the images are recorded for future 
review with X-ray technology [16]. The femoral or brachial arteries are used for 
catheterization of coronary catheters which distribute the dye, or a contrast media, into 
Chapter 1: Introduction 
 8 
the coronary vessels. The dye (a radio-opaque contrast agent) is visible by X-ray, and as 
the dye is being injected into the vessel, X-rays are being generated and captured to 
visually capture on a monitor how the dye is flowing through the vessels of the heart. 
This typically helps physicians identify and locate where there is an occlusion within the 
heart. Figure 3 is a Coronary Angiography, or X-ray image that captures the dye as it 
flows through the coronary arteries. This X-ray image of the contrast agent within the 
blood of the coronary arteries allows visualization of the size of the artery lumen. This 
information allows physicians to determine if a coronary disease is present.   
 
 
Figure 3: Coronary Angiography Image 
The purpose of coronary angiography is to define coronary anatomy and the 
degree of lumen obstruction of the coronary arteries and remains the standard for 
providing physicians a vehicle to determine the location of potential coronary disease in a 
patient [17]. Information obtained from the procedure includes identification of the 
location, length and diameter of lumen, and contour of the arteries; the presence and 
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severity of obstruction, characterization of the obstruction (i.e. presence of atheroma, 
thrombus, dissection etc), and the nature of blood flow. There are three clinical situations 
in which coronary angiography is used [18]: (1) to determine the presence and severity of 
CAD in a setting in which the diagnosis is uncertain and CAD cannot be assessed by 
noninvasive testing such as an echocardiogram or an electrocardiogram, (2) to assess the 
appropriate form of intervention, such as revascularization or percutaneous surgical 
intervention, (3) as a research tool for the assessment of treatment results and the 
progression or regression of CAD [17].  
 Limitations of Coronary Angiography 
Angiography has been the principal clinical tool for determining the severity of 
luminal stenosis [15;17]; however, considerations regarding the accuracy and 
reproducibility of coronary angiography are not to be overlooked.  
The resolution of modern angiographic equipment, in the clinical setting, is 
limited to approximately 0.2mm due to the effect of motion artifact, angle of imaging, 
overlap of vessels, and image display resolution [19].  Other risks associated with this 
invasive technique include: arterial puncture, iodinated contrast, and radiation. External 
limitations include multiple staff members, costs, and the long observational period [17]. 
In 1992, the mean cost for cardiac catheterization for inpatients younger than 65 years 
was $10,800 which may vary by state [20], but by the year 2000 the average total cost for 
patients hospitalized for diagnostic cardiac catheterization increased to $16,838 [21].  
In clinical practice, the degree of coronary arterial obstruction is expressed as a 
percent of diameter stenosis. Percent stenosis is done by comparing the diameter of the 
site of minimum lumen diameter segment to an adjacent segment that seems to be free of 
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disease and is subject to visual assessment. When luminal narrowings are present on an 
angiogram, further analysis almost always demonstrates severe obstruction; however, the 
converse is not true. A normal angiogram does not exclude atherosclerosis, in fact, most 
studies suggest that coronary angiography underestimates the severity of CAD [22;23]; 
there are several factors that contribute to this discrepancy.  
First, coronary angiography illustrates coronary anatomy from a planar, two-
dimensional silhouette of the contrast-filled lumen (see Figure 3); however, lesions are 
often very complex such that one angle of view may misrepresent the severity of 
narrowing [24]. This can be especially difficult in the left main coronary artery where 
two orthogonal angiograms may not accurately demonstrate the severity of lesions as 
these orthogonal views are unobtainable because the stenosis may be obscured by 
overlapping side branches [25].  Figure 4  provides an illustration of A) The direction of 
the X-ray is above a vessel with plaque orthogonal to direction of scan; B) illustrates 
what the X-ray image would be interpreted as, as if there were no obstructions to the 
vessel (black color represents contrast agent); however C) illustrates what the image of 
the vessel would look like if the scan direction was rotated 90 degrees, showing a clear 
obstruction within the vessel (black being flow of contrast agent, and white being the 
vessel obstruction).   
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Figure 4: Illustration of Coronary Angiography Limitation: A) represents a vessel with plaque 
orthogonal to the direction of the X-ray scan. B) Illustrates what the angiography image would look like 
while X-ray scanning was orthogonal to plaque. (Black fill color represents contrast agent). C) Illustrates 
what the angiography would represent if the scan direction were rotated 90 degrees (going into the paper), 
indicated a clear obstruction within the vessel lumen. 
 
Second, coronary “remodeling” may contribute to the inability of coronary 
angiography to identify mild CAD [2;7;26-28]. Remodeling is a vascular enlargement of 
plaque during the early stages of plaque accumulation, thereby concealing the 
atherosclerosis from the angiogram. Once this atheroma becomes severe, the external part 
of the vessel begins to enlarge, and atherosclerosis becomes evident. These unseen 
lesions have been reported as a predisposing cause of acute coronary syndromes such as 
myocardial infarction (MI) [29]. Figure 5 provides an illustration to depict how coronary 
remodeling occurs within the vessel walls. In this case, during angiography, plaque build 
up goes undetected as the contrast agent is able to travel through the vessel lumen 
unobstructed.   
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Figure 5: Coronary Remodeling: Coronary remodeling occurs when plaque builds up within the vessel 
walls rather than within the lumen. Coronary angiography would not capture the disease as the contrast 
agent would not be restricted from flowing through the lumen.  
 
Third, coronary angiography only visualizes the lumen of the vessel and cannot 
determine if the wall of the reference segment has CAD [22;30]. In the presence of 
disease within the reference segment, percent stenosis will underestimate the true amount 
of lumen narrowing [17;22;30].  
These limitations have resulted in the development of new imaging methods to 
help improve the assessment of CAD. Although these new techniques have not replaced 
coronary angiography, they have provided additional valuable information that has 
allowed further assessment of the severity and extent of lumen obstructions. Despite its 
limitations, angiography still remains as one of the principal clinical tools in the 
assessment of CAD. 
 
Intravascular Ultrasound (IVUS) 
 Intravascular Ultrasound is an imaging technique that provides high-resolution, 
real-time visualization of vessel morphology in vivo.  Delineation of arterial wall 
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structures has become imperative in the cardiovascular field, as cardiovascular  diseases 
(CVD) continue to take the lives of millions each year [1].  Despite the prevalence of 
these diseases, IVUS technology provides imaging methods to properly diagnose and 
intervene on patients who suffer from a CVD.  Such methods include quantitative and 
qualitative tools for acquiring accurate measurements of cross-sectional dimensions of 
the arterial lumen [2;28], visualization and assessment of atherosclerotic plaque [2;31], 
delineation of arterial wall morphology [2], and evaluation of the outcome of an 
intravascular intervention [2;28]. Overall, IVUS provides a tomographic perspective of 
lumen geometry and vessel wall structure that other diagnostic imaging techniques 
cannot. 
IVUS is an invasive catheter-based technique that is widely used to assess 
atherosclerotic plaque [32]. At the tip of an IVUS catheter, a transducer emits an 
ultrasound pulse and receives the reflected backscatter signal from the tissue where this 
backscattered signal is then processed real-time into a 2D image. The image permits 
accurate delineation of the vessel and lumen, dimensions, distribution and severity of 
coronary plaque [33;34].  
An imaging catheter is typically inserted percutaneously into the femoral artery 
and directed by a guide-wire into the chambers and vessels of the heart (see Figure 6). 
The imaging catheter differs in length and diameter based on the vessel being imaged. At 
the proximal end of the catheter (end closest to physician), the catheter is connected to a 
motor-drive unit that is used to spin the drive cable within the catheter sheath. This drive 
cable is what spins the ultrasound transducer 360° and as the transducer is rotated by the 
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drive cable at approximately 1800 rpm, the transducer generates and receives ultrasound 
pulses to and from the coronary tissue.  
 
 
Figure 6: IVUS Catheter in Artery: A mechanical IVUS catheter being pulled back with a coronary 
vessel to expose vessel morphology. [Image provided by Boston Scientific] 
 
The echoes, or received ultrasound pulses reflected by the tissue, are captured by the 
transceiver and converted from a mechanical signal (or vibration) to an electrical signal 
down the drive-cable. The electrical signal is then digitized and rendered onto a display, 
providing the physician with a 360° cross-sectional view inside the coronary vessel (see 
Figure 7).  
 
Figure 7: IVUS image: Representation of a standard IVUS gray-scale image providing a 360° view of a 
coronary vessel. [Image provided by Boston Scientific] 
Transceiver 
Plaque 
Drive Cable Guidewire 
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Traditionally, coronary angiography has been used to provide a two-dimensional 
silhouette of the lumen in coronary vessels to detect the degree and severity of stenosis. 
Angiography heavily relies on the positioning of the system during imaging, since it only 
provides a silhouette of the lumen, a physician may be incapable of properly diagnosing 
he severity of atherosclerosis. Coronary IVUS is most often performed in conjunction 
with coronary angiography. During an IVUS intervention, arteries as small in diameter as 
1.5 mm can typically be visualized and typically the patient is given intravenous heparin 
and intracoronary nitroglycerin which prevents blood coagulation within these small 
coronary arteries. The procedure is typically performed by a cardiologist or interventional 
cardiologist in a cardiac catheterization laboratory. IVUS imaging provides a 
tomographic 360-degree sagittal scan of the vessel media (blood) to the vessel wall. 
IVUS measurements of arterial dimensions (minimal and maximal diameters, cross-
sectional area, and plaque area) complement and enhance angiographic information. 
When a mechanical pullback of the IVUS catheter is performed at a fixed rate, a three-
dimensional (3D) reconstruction of the artery can be obtained [35;36]. More details on 
how IVUS works will be discussed in a later section.  
Limitations of IVUS 
 As is the case with all technologies, there are limitations. One of the biggest 
setbacks with IVUS technology is image interpretation. The technician studying the 
images needs a solid understanding of the potential ultrasound artifacts. Generally, 
artifacts are easily recognized, but in some cases artifacts may adversely affect the image 
quality,  and ultimately increase the difficulty of interpretation and reduce the accuracy of 
the quantitative measurements [23;37].  
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 Artifacts are structures and features on an image that do not have a one-to-one 
correlation to the object being scanned. Non-uniform rotational distortion (NURD), ring-
down and geometric distortion are common artifacts that make image interpretation 
difficult. NURD is only found in mechanical systems (explained later) and is caused by 
uneven mechanical drag on the catheter drive shaft that results in cyclical oscillations in 
rotational speed. Ring-down is a phenomenon that occurs immediately around the 
catheter and results in bright circular areas in the image that can interfere with image 
interpretation when the transducer is close to the arterial wall. Geometric distortion 
results from imaging in an oblique plan, creating an elliptical, rather than circular, cross-
sectional image.  
Another major limitation of IVUS is its low specificity for the diagnosis of a 
thrombus. A thrombus, or blood clot, occurs when blood vessels are damaged and cause 
platelets to adhere to the damaged endothelial cells; in most cases, the formation of a clot 
is due to ruptured plaque. The formation of a thrombus on top of ruptured plaque is 
considered to be a sign of an acute coronary syndrome and the use of IVUS to determine 
the amount of clot contributing to a stenosis would greatly assist in clinical decision 
making [23;38-40;40]. The limitation is due to the fact that a thrombus, under IVUS 
image interpretation, looks similar to plaque tissue therefore making it difficult to 
differentiate.  
Optical Coherence Tomography (OCT) 
OCT is similar to Intravascular Ultrasound (described later) but instead of 
acoustic waves, a light source is emitted towards the sample [41]. The time delay 
information and intensity of backscatter of light from the varying internal structures vary 
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with optical properties. Because the speed of light is so fast, OCT uses a technique called 
low-coherence interferometry, where light reflected back from the sample is measured by 
correlating it with light that has travelled a known reference length. OCT uses near 
infrared light, ~1300 nm, because light with a shorter wavelength is prone to a higher 
degree of scattering and absorption, while light with a longer wavelength results in 
undesirable absorption attenuation. With OCT, a spatial resolution of 4 to 16 µm is 
achieved with a penetration depth of 2 to 3 mm. [42-44]  
Limitations 
One of the major limitations for OCT is that it requires a blood-free zone for 
imaging that is accomplished by a saline flush or an occluding balloon. This is because 
light is significantly absorbed and scattered by blood cells, which degrades the coherence 
and image quality. Overall, it is a cumbersome procedure compared with other imaging 
modalities [42-44]. Another limitation of OCT is that its depth range is limited to 
approximately 3-4mm and depth penetration in tissue is limited to 1-3 mm, which limits 
imaging beyond the internal elastic lamina [42-44]. Additionally, stent struts appear as 
bright local reflections with shadowing sectors radially behind them, which gives the 
tendency for OCT to underestimate the stent strut thickness in reference to 
manufacturers’ specifications especially when blood is present [45]. Despite its 
limitations, studies demonstrate the feasibility of cardiac OCT to visualize coronary 
disease in patients [42-44].  
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1.1.6 History of Intravascular Ultrasound 
The start of ultrasound technology first began in 1880, where Paul and Jacques 
Curie discovered that in some materials (notably crystals) an electric potential is 
generated in response to mechanical stress (deformation); this technology was given the 
name piezoelectricity. Similarly, the reverse was found true [46]. Consequently, 
subsequent discoveries were made that led Sokolov to believe ultrasound could be used 
for the detection of flaws in materials [47-49]. Later, in 1937, Sokolov was awarded a 
patent for his ultrasound flaw-detection device [48]. It was not until 1942 an attempt was 
reported on using ultrasound as a diagnostic tool. However, Meyer reports of earlier 
applications of ultrasound for use in medical therapeutics [49]. 
Neurologist Dr. Karl Dussik of Vienna, Austria, was the first to attempt to use 
ultrasound as a diagnostic tool in 1942 [49;50]. Dussik’s attempt was based on the 
transmission method, where a sample (in this case the skull) was exposed to a beam of 
ultrasonic rays by one transducer and recorded by another on the opposite side of the 
sample. The changes in attenuation that traversed through the sample were recorded on 
an oscilloscope. In 1952, Guttner et al. determined that the transmission method was of 
no value due to the absorption and reflection of the bones within the cranium [50] and 
another method was soon reported, known as the reflection method.  
In 1949, Ludwig and Struthers attempted to use the reflection method to detect 
gallstones and other foreign elements deep within the muscle of dogs [50]. The reflection 
technique is where both the transmitter and receiver are located on the same side of the 
sample under examination. Sound pulses are emitted for long intervals, where a fraction 
of the sound is reflected by tissues with different densities – every kind of tissue has 
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characteristic impedance that makes its reflection distinguishable. The reflected pulses, or 
echoes, are recorded on an oscilloscope.  
The development of ultrasound as a medical diagnostic and therapeutic tool in 
cardiology began in the early 1950’s. Inge Edler, a cardiologist, and Carl Helmuth Hertz, 
a physicist, collaborated together to see if ultrasound technology could be used to 
examine the heart.  Their first work entailed using a sonar device, or reflectoscope, to 
record echoes from Hertz’s own heart [49].  However, as is the case with most 
technologies, the rise of ultrasound in cardiology evolved from other applications of 
ultrasound, as it was Edler’s job to evaluate cardiac patients prior to heart surgery  [51].  
Simultaneously, researchers such as Dr. Wild and Dr. Reid from the United States began 
ultrasound studies on the human heart [47;52].  
In 1966, 10 years after Wild and Reid first began studying the heart, Kossoff 
described a catheter tip transducer of 2mm in diameter operating at 8 MHz for measuring 
ventricular wall thickness [53]. A few years later, a group applied a 2.5 MHz cylindrical 
element that radiated through a 360° arc [54]. At the same time, Stegall et al. introduced 
two transducers mounted at the end of a catheter to determine the intra-aortic and intra-
carotid diameter [55]. However, it was Wells, in 1966, who first came up with a practical 
design using an intravenous probe with mechanical rotation and a flexible shaft for 
rotational real-time cross-sectional imaging [56]. But despite all these advancements in 
intravascular ultrasound, there were many limitations that made IVUS imaging 
impractical for clinical use such as not being able to conduct real-time analysis. Thus, 
Bom et al set out to develop invasive real-time and cross-sectional ultrasonic imaging 
using state-of-the-art technology. His group developed a 32-element circular phased array 
Chapter 1: Introduction 
 20 
mounted on the tip of a catheter to record real-time intra-luminal images of ventricles in 
animals; however, the catheter size and steerability provided serious limitations [57].  
The simplest approach has been circumferential scanning with a single transducer 
to provide cross-sectional imaging through the blood of the arterial wall under the 
endothelial surface. The mechanical single-element design was investigated by many 
groups and chosen over the electronic multi-element system as described by Bom. The 
electronic multi-element phased array ultrasonic catheter allowed for a reduction in the 
number of electrical wires, thus, a smaller size catheter with greater flexibility. However, 
the main problem with the phased-array technology is that it was complicated and 
expensive. Resolution and artifacts in the near field put limitations on the technology for 
smaller diameter vessels and stenosis. These complications made the single-element 
design much more attractive. The single-element is a design where the transducer was 
mounted in the axis of the catheter where the ultrasound can be swept around in a plane 
perpendicular to the catheter’s long axis by rotating the transducer (in a manner similar to 
a lighthouse) to obtain a 360° display of the arterial cross-section. This technology was 
great for imaging small arteries (i.e. coronary arteries) as the single transducer at high 
frequencies (>20 MHz) had great attenuation with distance. [58]  
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Chapter 2: Basic Principles of Ultrasound 
In order to gain a greater understanding of the fundamentals for intravascular 
ultrasound imaging, it is necessary to review some of the physical mechanisms that relate 
to ultrasound and using ultrasound for coronary imaging. The following section provides 
a survey of mechanical and acoustic principles for ultrasound imaging. 
 
2.1 General 
Sound can be described as a mechanical energy that propagates through a medium, 
these are called – pressure waves. Ultrasound is defined as sound waves with frequencies 
above the upper limit of human hearing of 20 kHz. Ultrasound imaging is based on the 
reflection method (or pulse-echo method as described previously), where a short 
ultrasound pulse is transmitted and received by the same source (transducer) that converts 
electrical energy into acoustic energy, and vice versa. In the application of IVUS, the 
transmitted ultrasound pulses travel through various coronary tissue and are scattered, 
reflected and refracted at tissue boundaries. The scattered and reflected ultrasound waves 
are called echoes; the receiver detects the acoustic vibrations and converts the vibrations 
pulses back into electric signals for the IVUS system to interpret. Although there are 
many diagnostic ultrasound applications, cardiology is one of the few fields that use high 
frequency (>10 MHz) ultrasound as a diagnostic tool.  
Before discussing the in-depth details of Intravascular Ultrasound, it is necessary to 
discuss some of the fundamental concepts of ultrasound physics.  This next section (Sec 
2.2) is for novice readers and may be skipped by those who are familiar with the basic 
concepts of ultrasound physics. 
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2.2 Ultrasound Waves 
Unlike most of the waves we encounter on a daily basis, ultrasound waves are 
longitudinal mechanical waves that propagate at a frequency greater than 20 kHz – 
beyond the range of human hearing.  Mechanical waves are such that they need a medium 
for propagation, unlike electromagnetic waves that travel at the speed of light and do not 
need a medium to propagate.  Mechanical waves travel through deformable, elastic 
mediums as the energy of the wave causes displacement of the medium particles. The 
energy in the mechanical waves is transmitted through the motion of the particles, where 
the medium itself does not move from one place to another. In other words, ultrasound is 
the transmission of mechanical vibrations through a medium.  
Mechanical waves are categorized as either longitudinal or transverse, which 
correlates to the direction of the displacement of the individual particles of the medium. 
All acoustic waves are longitudinal, where the particles in the medium move parallel to 
the direction of the wave; conversely, transverse waves cause particles to displace 
perpendicular to the direction of the wave. To visualize how an ultrasound wave 
propagates, imagine the individual particles are connected to each other by springs. An 
incident wave will cause the first particle to compress the spring between the first and 
second particle. This compression energy is then transferred between particles two and 
three and particles one and two undergo what is called rarefaction, this is a result of each 
particle oscillating about its equilibrium point every time a wave passes [59].  
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2.2.1 Frequency 
 Describing the temporal behavior of a sound wave is useful when modeling 
ultrasound waves. The description of compression and rarefaction above will give us 
something similar to a sine wave if we were to plot pressure versus time. Think of 
acoustic pressure the same as atmospheric pressure. During compression, the acoustic 
pressure is elevated above atmospheric pressure, and during rarefaction, the acoustic 
pressure corresponds to where the pressure is lower than atmospheric pressure. The 
resultant number of times per second either compression or rarefaction occurs at any 
point is called frequency. The frequency of a sound wave is determined by the number of 
oscillations per second made by the sound wave (e.g. sine wave).  
 The time it takes for the wave to complete a cycle is called the period. Period (T) 
and frequency (f) are inversely related as shown [60-62]: 
 
     fT
1
=       1 
 
2.2.2 Characteristics of Ultrasound 
The propagation speed c of sound waves in a medium is determined by its bulk 
modulus E and density ρ, where a more dense material has a greater the speed of sound 
[60-62]:  
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ρ
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The Intensity I of a sound wave, of the flow of energy through the unit area at a point is 
related to the pressure amplitude p by [60-62]: 
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The physical property of a medium which determines the reflection of sound waves is its 
acoustic impedance Z, the product of propagation velocity c and density ρ [60-62]: 
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The wavelength λ, the distance between two consecutive points of equal pressure, is 
related to the frequency f and the propagation speed c as follows [60-62]: 
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For a given medium, the higher the frequency the smaller the wavelength will be. The 
propagation of a sound wave in tissue is influenced by physical effects of which the most 
important are reflection, refraction, scattering, and absorption.  
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2.2.3 Reflection and Refraction 
  As a sound wave passes from one medium to another with different acoustic 
impedances, a part of the incident wave is reflected at the boundary and a part is 
transmitted through to the second medium, generally with an altered direction of 
propagation, better known as refraction.  
 
The angle of the reflected wave is equal to the angle of the incident wave. The angle of 
the refracted wave depends on the velocities of sound in the first and second media, 
which is given by Snell’s law [60-62]: 
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The ultrasound speeds in biological soft tissues are very similar and there is only a little 
deviation from the direction of the incident wave, which may be ignored.  
 
The reflection coefficient R, the ratio for the reflected intensity IR and the incident 
intensity II, is determined by the acoustic impedances Z1, Z2 of the two media, the 
incident angle, and the angle of refraction [60-62]: 
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In the case where the incident wave is normal to the boundary, where θ1 = 0°, the 
calculation of the reflection coefficient R is much simpler [60-62]: 
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The acoustic impedances of different soft tissues are slightly different, such that the 
reflection coefficient is very small. At boundaries between soft tissue and bone or air, a 
substantial part of the incident energy is reflected. Reflection and refraction describe the 
phenomena at smooth boundaries with large dimensions compared to the wavelength. If 
the boundary is not smooth, parts of the incident wave is reflected in different directions, 
so in addition to the directed specular reflection (e.g. mirror) there is non-directional 
reflection. 
 
2.2.4 Scattering 
 If a sound wave strikes a boundary layer that is not smooth, where the dimensions 
are comparable with or smaller than the wavelength, then part of the intensity of the wave 
is scattered in all directions. The discontinuities at the boundary layer are local changes in 
compressibility, density, or even both. The scattered parts of the wave resulting from the 
randomly distributed scatters may superimpose. Thus, there may be an enhancement of 
the intensity or the waves may cancel. Tissue is a grainy medium and because it is 
composed of cells, the scattering of the grainy medium is the reason why the 
homogenous regions of tissue show a “speckle” structure in ultrasound images.  
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2.2.5 Absorption and Attenuation 
 Scattering and reflection of a sound wave propagating in tissue is not the main 
reason for loss of energy; absorption is another primary factor in the loss of energy of 
sound waves. The mechanical energy of the wave is transformed into heat which is 
dissipated within the medium. The absorption depends on the medium and strongly 
increases with frequencies in the frequency range used in medical diagnosis. The 
exponential laws describe the amplitude A and the intensity I of the wave on the traveled 
distance [60-62]: 
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The absorption (attenuation) coefficient γ is in units dB/cm. Blood is known to have an 
attenuation coefficient of 0.2 dB/cm at 1 MHz [58] – This value changes as the frequency 
changes nonlinearly with frequency.  
 
2.3 Ultrasound Transducer Properties 
 As mentioned previously, in general, a transducer refers to a device that converts 
signals or energy from one form to another. Ultrasound transducers are used to convert 
acoustic energy to electrical signals and electrical signals to acoustic energy; they are 
used to detect and transmit ultrasound waves.  
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 Transducers used for medical ultrasound imaging employ the piezoelectric effect 
to generate and detect sound waves (as described in Chapter 1). There are a number of 
piezoelectric materials such as quartz that are used for diagnostic ultrasound, but lead 
zirconate titanate (PZT) is the most common ceramic used in ultrasound imaging [61]. 
These materials must be polarized before they can transmit and receive sound waves 
effectively. This is done by heating the material above 36.5° C, for PZT, and then 
applying a high voltage across the material to align the crystals, which is also known as 
polarization. The material is then cooled with the voltage still applied as this will allow 
the material to maintain polarization, giving it the desired piezoelectric properties [61].  
The speed of sound and thickness of a piezoelectric material determine its center 
frequency. Transducers are also characterized by their transmit and receive sensitivity, 
both as a function of frequency. The center frequency and bandwidth determine the pulse 
length of the transducer. A transducer that is sensitive over a wide range (high 
bandwidth) of frequencies can transmit short, broadband pulses. These properties are 
essential is determining a transducers’ spatial resolution and will ultimately effect image 
quality.  
 
2.3.1 Solid-State vs. Mechanical Transducer Elements 
A 360° cross-sectional tomographic image is produced with a variety of 
technologies. Solid-state technology uses a circular multi-element phased-array of 
transducer elements on the tip of a catheter (see Figure 8). The image is created by 
sequentially firing the array of transducers, and simultaneously receiving echoes by 
programming one set of transducers to transmit and another to receive.  
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 Mechanical technology uses a single element transducer located at the tip of a 
catheter (see Figure 8). The transducer is rotated mechanically via a flexible drive shaft 
connected to a drive motor. The transducer transmits and receives ultrasound signals at 
approximately 1.5° increments to create the tomographic image. The transducer element 
provides 256 vectors, or scan lines, for each image. The motor drive at the end of the 
catheter facilitates uniform mechanical pullback of the transducer within a protective 
sheath. The experiments performed in this thesis used the single element mechanical 
technology just described.  
 
 
Figure 8: Multi-element and single element technologies [Image provided by Boston Scientific] 
 
2.3.2 Resolution 
Due to its ability to provide detailed in vivo images of coronary vessels, IVUS has 
assumed the role in the diagnosis and treatment of coronary artery diseases. As IVUS 
technology progressed, a wide array of systems, catheters, and transducers have been 
developed to provide enhanced image quality. IVUS image quality is especially 
important in that detecting the small differences may play an important role in identifying 
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vulnerable plaque in a vessel or determining the outcome of specific therapy. There are 
many key players in IVUS that enhance the quality of the system overall; these basic 
principles are what drive the success of an intravascular ultrasound system, and the main 
component being the transducer as it drives the resolution capability of the entire system. 
 
Spatial Resolution 
 Optimizing resolution is one of the most important elements in an ultrasound 
system; the better the resolution, the better the image quality (i.e. clarity).  Resolution is 
the minimum distance two targets can be distinguished on a display.  There are two types 
of resolutions important to ultrasound imaging: axial and lateral resolution, both of 
which are directly related to the transmission frequency and transducer used and are key 
elements in the image quality for IVUS.   
 
Axial Resolution 
Axial resolution is the resolution along the axis of the ultrasound beam, and is 
determined by the pulse length (determined by transducer frequency and bandwidth) - the 
shorter the pulse length (i.e. higher the frequency), the greater the resolution and is 
described by the following:   
 
Axial Resolution = spatial pulse length (SPL) / 2 
   Where SPL = λ x no. of cycles 
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The axial resolution of a transducer is generally better than its lateral resolution, 
where the axial resolution for a 20 MHz transducer is 200 microns and approximately 
100 microns for a 40 MHz transducer [58]. Figure 9 provides a visual diagram to help 
better understand this characteristic. Axial resolution is dependent on the pulse length. 
Because the ultrasound pulse is small enough in this example, the transducer will pick up 
two reflections. As the scattering elements approach each other, the pulse becomes longer 
in comparison, thus only one reflection will be seen by the system.  
 
 
Figure 9: Axial Resolution Representation The black box represents the transceiver element rotating 
360° within the catheter. The scattering elements are the black, small and round dots. A) Represents the 
ultrasound signal (US) being emitted from the transceiver traveling towards the scattering element. The US 
spatial pulse length is represented byt eh magnitude or length of the black arrows. B) As the US hits the 
first scatterer, a portion of the US is reflected back to the transceiver while another portion is transmitted 
through the element towards the next element. C) The first reflected US hits the transceiver while the 
second reflected US begins traveling towards the transceiver. D) The final reflection from the second 
scatterer reaches the transceiver at a time after the first, enabling the transceiver to differentiate between 
both reflections. Axial resolution is dependent on the pulse length. Because the ultrasound pulse is small 
enough in this example, the transducer will pick up two reflections. As the scattering elements approach 
each other, the pulse becomes longer in comparison, thus only one reflection will be seen by the system. 
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Lateral Resolution 
Lateral resolution can be described as the resolution perpendicular to the beam 
axis and is directly related to the beam cross-section (See Figure 10). Said differently, it 
is the ability to distinguish adjacent targets perpendicular to the ultrasound beam. Lateral 
resolution is determined by the geometry of the transducer (the diameter) and 
transmission frequency.  Basically, two objects side by side (see Figure 10) cannot be 
distinguished if they are separated by less than the beam width of the transceiver. The 
determinants of beam width are transducer frequency where beam width increases with 
lower frequency transducers and vice verse. We already know that resolution increases 
with frequency, however, attenuation of the ultrasound wave increases as the frequency 
increases, and as a result, the penetration depth is limited.  This is due to the US wave 
becoming smaller in wavelength, making it unable to penetrate elements that are bigger 
than the wavelength itself. Consequently, non-invasive ultrasound imaging is performed 
at 1-5 MHz in order to optimize the penetration depth [63].  High frequency ultrasound 
applications (>10 MHz) have penetration depths of <1.5cm, but have higher resolutions 
(<200 µm).  Typical 40 MHz IVUS transducers provide approximately 0.5 mm of lateral 
resolution [58]. 
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Figure 10: Lateral Resolution Diagram This illustration shows that the beam width, or diameter of the 
transducer, determines the lateral resolution. The smaller the beam width, the more capable a ultrasound 
system can differentiate between two elements. Also, due to beam spreading, once the scattering element is 
beyond the focal point, lateral resolution begins to worsen as shown. This can only be improved by 
decreasing the size of the transducer itself. 
 
2.4 Intravascular Ultrasound System 
 A typical IVUS system consists of six main components as shown in the 
schematic below (see Figure 11): Catheter, motor drive unit, transmitter, receiver, signal 
processing module, and the display. The ultrasound transducer sits at the tip of the 
catheter. As described previously, the motor drive unit rotates the drive cable that the 
transducer sits on at 1800 rpm.  
 
Figure 11: Basic IVUS System Block Diagram 
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The transmitter generates short voltage pulses that are applied to the piezoelectric 
crystal in the transducer. The amplitude and frequency of the pulse can be adjusted with 
the system where a typical excitation pulse ranges from 50 – 100 V, with frequencies 
ranging from 10 – 40 MHz.  
The receiver amplifies the small voltage signals that are returning echoes from the 
tissue striking the transducer. Because ultrasound is attenuated as it travels through tissue, 
and because some scaterrer elements are further away than others, a time-dependent 
amplification, generally called time-gain compensation (TGC), is used to compensate for 
the attenuation loss and time delay. Attenuation occurs as an US signal penetrates 
scatterers (i.e. blood and tissue) causing some of the US energy to be reflected in 
different directions and never being detected by the transceiver. Filters and a master gain 
control are also used for noise reduction and global amplification if needed.  
Because the human eye can only distinguish about 200 different gray levels, the 
received echo signal is compressed by an adjustable logarithmic amplifier to avoid a loss 
of information when transformed into a video image – the dynamic range of the received 
signal is about 50 dB [58;61]. At the same time, the high frequency echo signal is 
demodulated to obtain an enveloped signal, or an intensity signal. Once this occurs, the 
intensity signal is then scan converted. Scan conversion is necessary because scanning of 
the vessel cross-section creates a series of intensity scan lines that have to be transformed 
for a 360° geometrical display. Closer to the transducer these scan lines may overlap, 
therefore, during scan conversion the intensity of pixels close to the transducer is 
calculated by averaging over several scan lines. Averaging over several images may 
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reduce image noise and may be used to increase image quality. Finally, the signal 
processed intensity signal is displayed on the video monitor. 
 
2.5 Physical Properties of Tissue Relevant to IVUS 
Although IVUS has proven to be a highly accurate imaging modality, widely used 
as a complimentary diagnostic tool to angiography, much of the research today is focused 
on methods of continuing to improve upon resolution and image quality. The focus of 
this study was to determine the feasibility of improving upon the blood-tissue boundary 
by using a multi-frequency enhancement method. Blood has shown to be frequency 
dependent, whereas tissue has not - perhaps this is due to the increase in the size of the 
scattering element [64]. Thus, understanding the physical and acoustic properties of both 
the blood and vascular tissue are of importance. The following sections will outline the 
results of previous studies on the physical and acoustic properties for both blood and 
arterial tissue.  
 
2.5.1 Properties of Arterial Tissue 
Mechanical Properties 
 There are three layers of an artery: the intima, media, and adventitia. The intima 
consists of the endothelium, which is a single-cell layer of connective tissue that 
encounters the blood within the artery. The media consists of smooth muscle layers 
composed of elastin and collagen fibers. The adventitia is composed of mostly collagen 
fibers. Thus, arteries are multi-layered anisotropic structures that are pre-stressed 
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longitudinally and circumferentially based on the orientation of the smooth muscle in 
each layer. Additional mechanical and acoustic properties relevant to this study are 
discussed further in the following sections.  
 
Acoustic Properties 
As with any media, ultrasound propagation through the artery results in 
attenuation and distortion of the ultrasound beam by refraction and diffraction. According 
to Duck [65], the speed of sound for whole arteries was found to be 1616 cm/s. This was 
verified by Saijo et al who reported an average velocity of 1619 ± 42 m/s [66]. Due to the 
physics of ultrasound, as the media in which the ultrasound is propagating in becomes 
more dense, the beam will propagate faster through the media. This incident was 
observed by Rooney et al as they report a velocity as high as 2000 m/s in diseases arteries 
with high level of collagen and cholesterol [67]. Attenuation in the arteries has been 
reported by [67-69]. The average attenuation for all three layers of the artery is 11 ± 4 
db/cm/MHz, higher in calcified regions, and lower in lipid regions.  
 Lockwood reported on the acoustic backscatter derived from arterial tissues [70], 
but these were not within the coronary vessels. Lockwood and other authors report that 
the acoustic backscatter measurements in the arteries have demonstrated higher 
backscatter in regions of calcification and fibrous plague compared to healthy arteries. 
However, none of which conclude that arterial tissue is frequency dependent. 
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2.5.2 Properties of Blood 
Intravascular ultrasound has become a valuable diagnostic tool in interventional 
cardiology, providing physicians with detailed, high quality, cross-sectional images of 
vessels. However, resolution and image quality are the primary focus of research. As 
described previously, resolution enhances the discrimination between various biological 
tissues. Therefore,  as the resolution increases, the image quality increases where the 
resolution of an imaging system greatly depends on the center frequency of the 
transducer. As the frequency increases, the axial resolution increases because it is 
determined by the length of the ultrasound pulse, which means, the shorter the pulse 
length, the greater the axial resolution. However, as the frequency increases, studies have 
noticed that there is a strong blood backscatter (echo) signal that makes blood appear like 
tissue, which may cause difficulties in the discrimination between the lumen and arterial 
wall boundaries [64;70;71]. Additionally, there are many other factors that may affect the 
echogenicity, or the tendency of tissue to reflect ultrasound, of blood backscatter. 
Researchers have reported that the hemodynamic and hematological factors such as 
hematocrit, protein concentrations, and blood flow dynamics [72;72-75] affect the 
echogenicity of blood; thus, the properties of scattering in blood should be well 
understood. In the following section, blood as a medium in ultrasound will be given.  
 
Physical Properties  
 Blood is composed of liquid called plasma where erythrocytes (red blood cells), 
leukocytes (white blood cells), and platelets are suspended. Erythrocytes are elastic, 
nonnucleated bioconcave disks with an average diameter of 7µm and a thickness of 2µm 
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[76;77]. The number of red blood cells is significantly larger than that of white cells and 
the volume of a red cell is much larger than that of a platelet [77]. Thus, scattering of 
ultrasound by blood is presumably due to red blood cells [76].  
  
Mechanical Properties 
Blood is non-Newtonian and is shear-thinning, such that the viscosity of blood 
decreases with an increase in shear rate [77]. The shear thinning properties of blood is 
known to be a result of changes in the aggregation and deformation behavior of the red 
cells [78]. At low shear rates, the red cells form rouleaux, in which the red cells join base 
to base, creating an interlocking structure so that the blood resembles a solid – essentially 
increasing the scatterer size and ultimately the echo intensity. An increase in shear rate 
breaks down the “bridging” between cells and reduces the rouleaux length, thus the 
number of individual blood cells increase. A study has shown that for shear rate in the 
range 0 to 1 s-1, aggregation dominates the viscous behavior, whereas in the range 1 to 
100 s-1, deformation is the dominant factor [79]. 
 
Acoustic Properties 
The backscatter signal from blood arises from the scattering elements that are 
individual red blood cells and red cell aggregates, called rouleaux. For scatterers small 
with respect to wavelength, there is Rayleigh scattering with dependence on transmit 
frequency, f, of f4, whereas scatterers large with respect to the wavelength show no 
dependence on transmit frequency [80]. A frequency dependence of f3.5 in whole human 
blood at a shear rate of 32 s-1 at 40 to 60 MHz was found by Foster [64]. A lower 
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frequency dependence occurs where aggregation is expected because of the larger size of 
the scattering particles [64;74]. Other factors such as red cell volume [81], transmit 
frequency [82], shear rate [74;83;84], hematocrit [84-86], fibrinogen concentration 
[82;87;88], turbulence [85], angle [89]and cycle length all influence the backscatter 
signal from blood. Fontaine et al. concluded that the main determinant in backscatter 
power is red cell aggregation [72]. Understanding these properties will provide a better 
understanding when trying to differentiate between red blood cells and arterial tissue 
during IVUS imaging.  
 
2.5.3 Blood versus Arterial Tissue 
The purpose of this study is to determine the feasibility of using a multi-frequency 
processing method to differentiate between blood and arterial wall, which will ultimately 
enable us to delineate the blood-tissue boundary and assess the degree of lumen reduction 
for atherosclerosis.  
First, in 1991, Lockwood reported that blood, at high frequencies (25-65Mhz) 
“was found to produce scattering that was within an order of magnitude of what was 
measured in some vascular tissues” [70]. Then, in 1994, Foster reported that at low shear 
rates and high frequency, the backscatter power from blood was comparable with the 
backscatter from the tissue media [64]. The force to improve upon image quality will lead 
to higher frequency imaging, and as Foster and Lockwood found, the frequency 
dependency of blood could increase the contrast on IVUS images where the 
discrimination of the blood-wall lumen would not be as easy to delineate compared with 
lower frequencies. The following experiment was designed in such a way as to determine 
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the feasibility of a method to increase the contrast between the blood-wall lumen 
boundary that is substantially grounded on the premises of prior studies. 
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Chapter 3: Multi-Frequency Processing for Lumen 
Enhancement 
3.1 Overview 
The use of high frequency ultrasound is the key to obtaining higher resolution 
IVUS images. As stated previously, the greater the transducers’ center frequency, the 
greater the image resolution. Consequently, increasing the transducer center frequency 
beyond that of the standard 40 MHz may introduce some challenges from stronger 
scattering intensities from blood as reported in the previous section by Foster [64] and 
Lockwood  [70]. This high level of blood scattering may obscure the arterial lumen and 
make image interpretation difficult for physicians [90]. However, frequency dependency 
by blood may provide the potential to distinguish blood from tissue by means of multi-
frequency processing techniques. In order to obtain a good blood-tissue contrast with 
sufficient signal-to-noise ratio, a system with a wider bandwidth is desirable. The 
proposed method is based on the Multi-Frequency Signal Ratio (MFSR) of the received 
signal power between the high (60 MHz) and low (25 MHz) frequency ranges of a novel 
wideband high-frequency coronary catheter. 
 
3.2 Materials and Methodology 
An experimental system, referred to as a phantom, was designed to allow 
simulated arterial ultrasound images to be collected and measurements to be made. 
Phantoms have been used in previous research to help interpret clinical scanning, validate 
measurements used in clinical practice and clinical research, and help characterize 
imaging systems in the development of new ultrasound techniques. The ultrasound 
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measurements taken using phantoms should be similar to scanning in patients. Imaging 
and measurement in vivo are critically dependent on the physical properties of the 
different tissues through which the ultrasound beam passes. Thus, it is critical that the 
relevant physical properties of the phantom be similar to human tissues.  
For this study, a flow phantom was designed to mimic the flow of blood through a 
coronary vessel of 4mm in diameter under steady flow conditions only. Due to the 
complexity and numerous effects associated with non-steady flow conditions, it was 
determined that a steady flow be used in this experiment as the main goal is to provide 
feasibility of a signal processing technique.  
 
3.2.1 Flow Phantom Setup  
Figure 12 shows a blood flow diagram of the experimental setup used for the in-
vitro study. The setup consists of a mechanical pump (Masterflex, Barrington, IL; Model 
No. 7520-40) to circulate the media throughout the model at a pump speed of 6 – 600 
rpm.  The system flow rate is monitored using a flow meter (Accucal®, Barnant 
Company; Model GF-6540-1230) that comes with a flow rate analysis software (Barnant 
Company; Model GF-4000) to correlate the flow meter scale reading (0-100) to an actual 
rate that depends on flow factors such as media density, viscosity, and temperature. Due 
to material and monetary constraints of this study a standard vascular phantom (ATS 
Laboratories, Bridgeport, CT; Model 524) was used to mimic coronary arterial tissue. 
The phantom consists of 4 lumen channels, 14 cm in length, with diameters of 2, 4, 6, and 
8 mm. For the purpose of this study, the center region of the 4 mm diameter channel was 
used because the 2mm channel does not provide a large enough imaging field for data 
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collection, while the 6 and 8 mm channels are not likely to be seen in clinical practice – 
most coronary arteries range between 2 – 4 mm [60]. The phantom is composed of a 
urethane rubber with a speed of sound equal to 1460 m/s with an attenuation coefficient 
of 0.5 dB/cm/MHz. Geometrical considerations of the vascular phantom will be 
discussed in the next section. This phantom was chosen for this study because it produced 
characteristics that closely reflect what would be seen in clinical practice.  
 
 
Figure 12: Blood Flow Model Diagram 
 
The actual setup is shown in Figure 13 and consists of two loops (see Figure 12): 
the main loop is used for porcine blood flow and imaging while the secondary loop is 
used to determine the flow velocity using Blood-Mimicking Fluid (BMF). Two loops 
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were used in this setup mainly because the color of the porcine blood would make it 
difficult to read the flowmeter scale, so the BMF which has more of a transparent 
characteristic was pumped in the secondary loop.  
The physical and acoustic properties of the BMF and human blood are compared 
in Table 1 below. The blood mimicking fluid consists of an Orgasol™ 5 µm nylon 
scattering particle and is described in further detail in previous work [91]. A sample of 
porcine whole blood was collected, with EDTA solution (25% HMT) as an anticoagulant, 
from a local animal laboratory. Within the main loop, the mechanical pump was used to 
control the flow speed within the system. Downstream from the pump is the vascular 
phantom that consists of a 4mm diameter channel made of rubber urethane. Due to its 
acoustic properties, the vascular phantom is used to mimic a coronary vessel in the heart 
and it is the location of the imaging window – the point at which the imaging catheter 
rests and performs imaging. A hot plate is used to control the temperature of the porcine 
blood at 37.5° C ± 0.5 by providing a feedback loop to the temperature controller. At the 
same time, a magnetic stir bar is placed within the blood reservoir to prevent aggregation 
within the flow loop. This temperature was chosen as it closely mimics the core 
temperature of human blood. As shown in Figure 13, the Masterflex tubes connecting 
each component together were tightly wrapped in aluminum foil. The purpose of this was 
to minimize the thermal loss experienced by the blood as it traveled through the system. 
At the same time, a heater pump (outside of view) was used to pump heated water over 
the top of the vascular phantom where most of the heat seemed to escape. A simple 
experiment showed that this method reduced the thermal effects experienced on the 
system by approximately 2° C. 
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Figure 13: Blood flow model setup. (1) Masterflex mechanical pump, (2) Blood-Mimicking Fluid, (3) 
Vascular Phantom, (4) Hot Plate, (5) Porcine blood reservoir, (6) Flowmeter. Not shown is a water pump 
that was used to pump warm water over the surface of the vascular phantom (3) in order to optimize 
thermal losses within the system, keeping the blood at a nominal temperature of 37.5° C. 
 
Table 1: Physical and acoustic properties of blood-mimicking fluid compared to whole human blood. 
Properties Human Blood (37°C) 
Blood-Mimicking 
Fluid 
Scatterer Red blood cells Orgasol™ (nylon particles) 
Scatterer size (µm) 7 5 
Hematocrit (% volume) 45 < 5 
Density (kg m-3) 1053 1037 ± 2 
Viscosity (mPa s) 3 4.1 ± 0.1 
Velocity (m s-1) 1583 1548 ± 5 
Attenuation (dB/cm/MHz) 0.15 0.05 ± 0.01 
 
 
1 
3 
5 
4 
6 
2 
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3.2.2 Vascular Phantom  
For this study, the imaging catheter was inserted into the 4mm diameter channel 
of the vascular phantom, approximately 7 cm into the lumen to ensure the entrance length 
of the fluid media had reached a full velocity profile. In long and straight pipes, we know 
the flow is axial and axisymmetric [92], and given that the channel is rigid, the velocity 
profile can be described analytically. In a straight channel, the velocity profile will 
change with time and distance from the entrance of the tube, remaining unchanged 
beyond a certain distance called the inlet length. For steady flow, the velocity profile 
beyond the inlet length is parabolic (see Figure 14). Generally, the insonation region is 
the region beyond the inlet length where the velocity profiles are stable with distance (i.e. 
where imaging occurs). For this study, the insonation region was within the 7 cm inlet 
length designed for the flow phantom. The formula for the inlet length is given by 
[92;93]: 
 
               edRL 04.0=      11  
  
where L is the entrance length, d is the diameter of the tube. In order to maintain laminar 
flow, the Reynold’s number must be less than the critical value of 2000 as given by [92]: 
    
µ
ρVdRe =      12 
 
where V is mean velocity, ρ is density,  µ is dynamic viscosity, and Re is the Reynolds 
number. Knowing the mean velocity and diameter of the vessel, we can determine the 
Reynold’s number, which is an indication of whether or not the velocity profile will be 
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stable. Given the physical properties of blood shown in Table 1 previously, the 
Reynold’s number calculated from equation 12, and outlined in  
 
 
 
Table 2, is valid for steady flow given the range of mean flow velocities. Thus, with a 
max Re of 421, a minimum entrance length of 6.73 cm is needed for a time-varying 
velocity profile to become fully developed; for this study, the designed inlet length 
satisfies the theoretical inlet length. 
 
 
Figure 14: Velocity Profile Diagram 
 
 
 
 
Table 2: Reynold's number and stability at varying mean flow velocities. 
Mean Flow Velocity 
(cm/s) 
Reynolds Number 
(Re) Flow Stability 
0 0 Laminar 
5 70 Laminar 
10 140 Laminar 
15 210 Laminar 
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20 280 Laminar 
25 351 Laminar 
30 421 Laminar 
3.2.3 Intravascular Ultrasound Imaging System 
The iLab™ ultrasound imaging system was provided by Boston Scientific 
(Natick, MA, USA). The imaging system consists of two PC’s and a motor drive unit. 
The acquisition PC is where the raw RF data is filtered, enveloped, and other digital 
signal processing methods are performed. The data was then transferred from the 
acquisition PC to an imaging PC, where the data is scan converted into a two dimensional 
grey-scale image. The motor drive unit (MDU) is another peripheral component to the 
iLab™ system and is the interface between the coronary imaging catheter and the iLab™ 
system. The coronary catheter had a center frequency of 40MHz and a bandwidth of 
80%. The MDU drives the cable shaft at 1800 rpm and sends the transmission pulse to 
the transducer element that is housed at the distal tip of the catheter.  
 
3.2.4 Coronary Catheter 
 
A coronary catheter with a novel transducer was used for this study in order to 
take complete advantage of capturing the high and low frequencies. Typical coronary 
catheter transducers have a center frequency of 40 MHz with a 40% bandwidth (BW). In 
other words, most of the used signal power, i.e. – 6dB fractional BW, from the transducer 
will range from 26 to 56 MHz. Using a catheter with such low BW will not allow us to 
capture data that can be differentiated between the high and low frequency (as will be 
explained later) – in this case, the high frequency would be 26 MHz and the low would 
be 56 MHz.  
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A novel transducer developed by Jian Yuan et al. [94] provided 80% BW. Figure 
15 provides a graphical representation of the difference in frequency response for a 
typical 40% BW coronary catheter and a high BW catheter at 80% BW, both with the 
same center frequency. Figure 16 now compares the frequency responses of the coronary 
transducers to a typical frequency response of blood and tissue. We can see that for a 
typical 40% BW catheter, the responses for blood and tissue are outside the boundaries as 
to where the catheter can perform. On the other hand, the blood and tissue responses 
seem to be enveloped by the frequency response of the 80% BW catheter.  
 
 
Figure 15: Frequency Response of High Bandwidth Transducer: The graph on the left represents the 
frequency response for a typical 40 MHz 10% BW coronary catheter transducer. The graph on the right 
depicts the frequency response of a higher bandwidth transducer, approximately 80%. [Image provided by 
Boston Scientific] 
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Figure 16 Blood and Tissue Frequency Response: The red dotted line portrays a typical blood frequency 
response while the green dashed line indicates the frequency response for normal arterial tissue. These 
tissues are prominent at different frequencies, which is the foundation of this study.  
 
 
This novel, high bandwidth, coronary catheter transducer enables this study to 
collect data at a low and high enough frequency to enable us to study the potential 
differences of backscatter response at those frequencies to determine frequency 
dependency.  
 
3.2.5 Data Acquisition and Analysis 
 
Two 12-bit, Agilent Technologies PCI analog-to-digital converter boards (Acqiris 
DP310, Monroe, NY), along with Matlab® software, were used to collect original RF data 
for post-processing analysis. The RF data was sampled at a 400 MHz sampling frequency 
and divided into a 2048x256 matrix, where one matrix represents a single IVUS frame. 
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The number of frames collected was not a factor for data analyses since imaging was 
performed at a stationary position where all frames essentially represent the same RF 
data. In order to determine the power ratio at each flow velocity, a fourth order 
Butterworth band-pass digital filter was used to suppress everything but the high-
frequency (60MHz 30% BW) and low-frequency (25MHz 80% BW) data from the 
original RF data set. The filtered data was then squared and averaged to determine the 
mean power signal.  
A region of interest (ROI) was selected within two to three millimeters from the 
center of the lumen to represent blood data within the vessel under study (see ROI#1 in 
Figure 17). ROI #2 represents data that reflects a region of the vessel comprised of tissue 
only. Each ROI contained 300 total samples of data, where 10 vectors of 30 samples per 
vector were collected.  
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Figure 17: Region of Interest (ROI): ROI#1 represents blood data collected within the vessel lumen. 
ROI#2 represents tissue data collected of the same vessel. Each ROI contains 10 vectors or columns of 
data, and each vector comprises of 30 samples for a total of 300 samples per ROI.  
 
High-frequency data (60MHz 30% BW) and low-frequency data (25MHz 80% 
BW) were collected for each ROI. Each vector was averaged and then the average of all 
the vectors within a ROI was calculated. For high-frequency data A60 represents the 
average power for a particular ROI. A25 represents the low-frequency average power for a 
particular ROI. Thus, in order to determine the Multi-Frequency Signal Ratio, or MFSR, 
the following equation was derived: 
   
25
60
A
AMFSR =
     13 
 
The MFSR, where the high-frequency data (average power signal) is divided by the low-
frequency average power signal, was calculated for each ROI.  
ROI #1 
ROI #2 
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The MFSR is what tells us if there is a correlation between the high-frequency 
(HF) filtered data and the low-frequency (LF) filtered data. The greater this ratio, the less 
correlation there is, meaning the HF and LF data do not match. In other words, the 
greater the MFSR value, the greater the sample is frequency dependent. If the HF and LF 
data do match, we would see a low MFSR value, indicating that biological tissue is not 
affected by frequency (frequency independent) and will be difficult to differentiate 
biological tissues using different frequencies. Figure 18 provides an overview of the 
post-analysis process. 
Before continuing on, it is important to note why the 60 MHz and 25 MHz 
frequencies were used for this experiment. As mentioned previously, the center frequency 
of the imaging catheter was 40MHz, but the important part is its ability to transmit with 
80% bandwidth. Essentially the catheter can transmit signals from 8MHz to 72 MHz. 
Since the transmitted power is max at the center frequency (40MHz) and derates at all 
other frequencies, we wanted to capture the highest and lowest frequencies that can still 
transmit a lot of power. At -3dB, 50% of the max power is being generated, so any 
frequencies within the -3dB range will suffice. The 25 and 60MHz frequencies lie within 
this range and provide a broad enough spectrum for testing the MFSR theory. 
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25 MHz Band-Pass Filter
Original Digitized RF Data 
set (2048x256)
Low-Frequency Data set 
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Power Signal
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Average Signal
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Low-Frequency Data set 
(2048x256)
High-Frequency Data set 
(2048x256)
Low-Frequency Data set 
(2048x256)
High-Frequency Data set 
(2048x256)
 
Figure 18: Multi-frequency post-processing analysis flowchart. The final step in this post-analysis process is to take the average of the averaged signal shown 
above, which is not shown. This final numerical value provides us with A60 and A25. Taking the ratio of A60 over A25, we can determine the MFSR and 
ultimately understand whether or not that particular sample is frequency dependent.  
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3.3 Results and Discussion 
 
3.3.1 In-Vitro Study 
  
The MFSR results for the porcine blood at various flow velocities and for the 
tissue mimicking wall are summarized in Table 3. Examining the data for mean flow 
velocity for blood gave us an MFSR of 2.77 (43.73 / 15.76 = 2.77), but the MFSR for 
tissue is 0.28 (17.44 / 61.18 = 0.28). As mentioned previously, the higher the MFSR, the 
more dependent the data is on frequency. The MFSR values of blood regions are 
consistently higher than those measured from the wall, where blood has an average 
MFSR value 8x greater than that of tissue.  What this means is that the intensity of the 
backscattering level for blood is much greater than tissue at higher frequencies, making it 
easy for an algorithm to detect which RF signals are blood and tissue. One interesting 
observation was the MFSR value was higher at the low flow velocities then at all other 
velocities, which may provide a unique advantage in detecting blood speckle under 
stagnant flow. The underlying physics of this phenomenon still need to be understood but 
can mostly be attributed to the rouleaux phenomenon – as described by previous studies 
cited in this chapter. This rouleaux phenomenon causes the blood cells to clump or stick 
together, essentially becoming denser and more echogenetic, or better said, the blood 
cells backscatter intensity will increase because the cell size increases. This method is 
advantageous over current blood detection methods used clinically in that those methods 
use a time-based correlation technique which does not work well in low flow 
environments as these methods expect blood to be rapidly changing continuously but is 
not always be the case. A more visual representation of Table 3 can be found in Figure 
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19 – the MFSR values are plotted against velocity, all other data from Table 3 was 
omitted from this plot.  
 The results in Table 3 give us insight into the ability to use the MFSR technique 
to clearly detect blood flow within a vessel and better delineate the lumen boundary 
between blood and tissue. As mentioned previously, this is advantageous because it 
enables physicians to better determine the lumen diameter of a diseased vessel and 
provide the right therapy.  
 
Table 3: MFSR results for whole porcine blood (37.5°C) and a tissue-mimicking media 
 Porcine Blood                    
(25% Hematocrit) 
Tissue-Mimicking Wall (TMW) 
Mean 
Flow 
Velocity 
(cm/s) 
HF 
Signal 
Power  
LF 
Signal 
Power  
MFSR 
HF 
Signal 
Power  
LF 
Signal 
Power  
MFSR 
0 71.12 27.36 2.59 16.25 54.99 0.29 
5 43.73 15.76 2.77 17.44 61.18 0.28 
10 35.13 14.75 2.38 17.75 57.07 0.31 
15 33.54 14.75 2.27 17.54 63.39 0.27 
20 33.40 14.9 2.23 15.61 48.48 0.32 
25 34.12 15.29 2.23 19.09 65.40 0.29 
30 37.04 15.91 2.32 18.52 67.05 0.27 
 
A quantitative analysis is shown in Figure 20 as it provides a plot of the 
backscatter intensity (amplitude) in the blood regions at varying flow rates. We can see 
that MFSR for blood is greater at all flow velocities at higher frequencies (60 MHz) 
compared to the lower frequency (25 MHz). It is important to note that there is a jump in 
intensity with blood at the stagnant flow region (0 cm/s) and can be associated with the 
lack of movement in the vessel and increased cell size of blood (due to rouleaux). When 
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the vessel is not moving the noise in the system is minimized and it will be easier for the 
receiver to pick up all signals from the cells (due to less interference), thus increasing the 
intensity of the received signal. Although blood has increased amplitudes at stagnant 
flow, we can attribute some of it to a stable, non-moving system rather than attributing it 
to this MFSR technique.  
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Figure 19: Mean Multi-Frequency Signal Ratio values measured in the blood-filled and wall regions 
with varying flow rates. The values are consistently higher for the blood than the tissue of the entire range 
of the flow rates. 
 
Chapter 3: Multi-Frequency Lumen Enhancement 
 58 
Mean Envelope Amplitude in Blood ROI 
0
10
20
30
40
50
60
70
80
0 5 10 15 20 25 30 35
Flow Velocity (cm/s)
A
m
pl
itu
de
 
(A
rb
.
 
Un
its
)
25 MHz Bandpass
60 MHz Bandpass
 
Figure 20: Mean signal amplitudes with the 60 and 25 MHz band-pass filters measured in the blood-
filled ROI. 
 
Appendix A provides an understanding of IVUS images and portrays the lumen 
enhancement technique implemented using the data captured from this in vitro study. The 
images portray the blood and tissue becoming more apparent at the frequencies used for 
this study and indicates visually that this method can be verified qualitatively. The left 
image is the conventional 40 MHz (40% bandwidth) IVUS image within the blood flow 
phantom as used in the study. The 40 MHz image shown has not been post-processed in 
any way. The middle and right images have been multi-frequency processed as described 
in the Data Acquisition section above.  
According to the studies presented earlier on the properties of blood and tissue, 
we would expect to see the tissue to be the most prominent scattering element when 
filtered at lower frequencies, and blood to be the most prominent scatterer at higher 
frequencies. The 25 MHz image in the middle clearly highlights the tissue mimicking 
media within the vascular phantom; the porcine blood is indistinguishable. However, the 
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60 MHz filtered image clearly distinguished the porcine blood in the image, and this time 
the tissue has been attenuated – suggesting tissue is frequency dependent at lower 
frequencies and blood is frequency dependent at higher frequencies. This comparison 
qualitatively indicates that there is a clear distinction between the blood and tissue when 
using the multi-frequency processing technique suggested in this paper.  
 
3.3.1 In-Vivo Study 
Figure 21: In vivo coronary image showing visual enhancement of a thrombus 
(Arrow). A) 40-MHz high resolution IVUS image. B) MFSR image obtained but the 
multi-frequency processing. C) Color-coded blood speckles to enhance the arterial 
lumen. The thrombus is difficult to recognize due to its echo intensities similar to 
blood, particularly, on the still frame.Figure 21 shows the lumen enhancement 
obtained from an in vivo animal study. This example demonstrates the ability of this 
method to produce a clean delineation between the arterial wall and blood.  
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Figure 21: In vivo coronary image showing visual enhancement of a thrombus (Arrow). A) 40-MHz 
high resolution IVUS image. B) MFSR image obtained but the multi-frequency processing. C) Color-coded 
blood speckles to enhance the arterial lumen. The thrombus is difficult to recognize due to its echo 
intensities similar to blood, particularly, on the still frame.  
 
 
This study helps qualitatively validate this multi-frequency technique. 
Furthermore, this study helps demonstrate the MFSR technique to produce a clear 
delineation of the thrombus, which is otherwise difficult to recognize because it was 
surrounded by blood speckles having similar intensities. 
3.4 Conclusion 
Strong scattering from blood due to the use of high ultrasonic frequencies has 
been a constant challenge for improving IVUS image quality. Most of the previously 
reported IVUS lumen enhancement techniques have taken advantage of the fast and 
random frame-to-frame movement of blood speckles in contrast to the slow and 
A 
B 
C 
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consistent motion from the tissue [95;96]. This motion contrast is also the most important 
visual cue to physicians unless saline is injected to flush out the lumen. One common 
drawback of a motion-based method is its inability to detect blood speckle effectively at 
low flow velocities, which is often seen in severe flow-limiting lesions. Other clinical 
applications, such as identifying small dissections, thrombi, or mild stent malappositions 
may also require dealing with a low flow condition where blood speckle does not always 
present a clear motion contrast. The unique advantage of the multi-frequency approach is 
that it does not rely on blood-tissue motion differences and, as demonstrated by the 
results in Error! Reference source not found., this method was able to enhance the lumen 
even when there was no blood flow (stagnant flow) in the phantom. Furthermore, this 
method does not require processing image data from multiple vectors or multiple frames, 
allowing it to be free of motion-induced smearing artifacts that may hinder a motion-
based method. 
One limitation of this method is the inhomogeneous image intensity due to the 
nature of ultrasound imaging. The MFSR value may vary significantly due to intensity 
variation of the speckle. Spatial averaging may be necessary to reduce this variation but it 
may also limit the resolution of the MFSR image.  
The multi-frequency processing technique verified that the backscatter power 
from blood is proportional to frequency as reported by other groups, where tissue does 
not seem to have the same response. In fact, it was found that at 60 MHz the tissue had 
been greatly attenuated, whereas the blood scatter power increased. At low shear rates 
(≤5 cm/s), the MFSR for blood was approximately 9x greater than the ratio for tissue. 
Furthermore, at high shear rates (≥20 cm/s), the MFSR for blood was an average of 7x 
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greater than the MFSR for tissue. This effect provides a feasible method for lumen 
enhancement, allowing physicians to better assess the blood-wall boundary and 
determine the severity of atherosclerotic region. Although tissue-mimicking media is 
designed to model in vivo tissue, there are a lot of dynamics that affect the attenuation of 
ultrasound and it would be beneficial to collect RF data from in vivo studies to better 
determine the accuracy of the multi-frequency technique described in this paper.  
The experimental technique described in this paper has the potential of being 
applied to flow velocity measurements. It was found that the MFSR decreased with 
velocity; however, further research needs to be performed on velocities greater than 30 
cm/s. 
As mentioned in previous sections, blood backscatter relies on many factors other 
than the flow velocity. It is recommended that further research be developed to 
understand whether or not the method proposed in this report would be clinically 
acceptable. Currently, detecting thrombus in IVUS is difficult as it has similar acoustic 
properties as an atheroma with high lipid content [97]. The MFSR technique, during un-
documented tests, indicated the detection of thrombus, which is a serious risk factor when 
diagnosing a patient. Further studies to ensure validity of these findings should be 
considered.  
As center frequencies increase to improve image resolution, more work on multi-
frequency processing at higher frequencies needs to be addressed since blood scattering 
may become so intense that it will then interfere with disease identification.  
Furthermore, flow velocity became apparent when analyzing the results during 
the study. Further work involving the MFSR technique to help estimate flow velocities 
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would significantly aid the characterization of disease within a vessel. If it was estimated 
that a low flow state was detected, then one might assume that the severity of the disease 
is significant and would require further investigation of the vessel.  
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Appendix A 
 
Figure 22: Enhanced Image Analysis: Standard 40 MHz IVUS image (Left). 25 MHz filtered image (Middle). 60 MHz filtered image (Right). This comparison 
clearly distinguishes the porcine blood at high frequencies and tissue at lower frequencies.  
 
 
The IVUS images above can be hard to understand if you are not familiar with IVUS technology. The image on the far left has 
not been post-processed in any way. Looking at this image you will notice in the very center a gray circle with bright rings around it 
(see Yellow arrow). This whole area is due to the catheter sheath that covers the transducer within the catheter. Essentially, this gray 
circle and bright concentric rings surrounding it can be ignored as they are not important when looking at IVUS images. When looking 
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at the rest of the image you will notice regions that are brighter than others (see Blue arrow). These regions correspond to normal 
tissue within the coronary arteries. Normal tissue is characterized by having a good scattering effect and long rod-like shapes. The red 
arrow indicates the region in which blood flows. The backscatter level here is typically lower than tissue and its texture much more 
fine than normal tissue – it can be better described as looking at static while watching TV.  
The middle image is a representation of the image on the far left, except this image has been post-processed and filtered at 
25MHz. This means only data within 25MHz will be present in the image. We can see from this image that tissue is more prominent 
and has a higher backscatter response at lower frequencies (see the Blue arrow), whereas blood is barely visible in this image. The far 
right image has been processed at 60MHz. Here it is evident that the blood is the most prominent scattering element in the image (see 
Red arrow) – it is also apparent that the tissue has been filtered. The difference between these two images is the essence of how the 
MFSR value is calculated and what enables the enhancement of the lumen boundary.  
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